Future Market Insights (FMI) estimates that the global Preterm Birth Diagnostic Test Kits Market was worth $121.3 million in 2021 and is projected to increase by 1.6 times over the next five years. The market is anticipated to expand at a CAGR of 7.6% from 2022 to 2028, with sales of US $ 203.2 Mn …
Category Archives: Healthcare Trends
Knotless Tissue Control Devices Market is expected to secure US$ 672.6 Million by 2032, at a CAGR of 3.4% | Future Market Insights
The global Knotless Tissue Control Devices Market is expected to reach US$ 672.6 million by 2032, growing at a CAGR of 3.4% between 2022 and 2032. The market is expected to be worth US$ 465.6 million in 2022. Over the past few years, innovative technologies have emerged to achieve excellent wound closure outcomes. Appropriate wound …
Hemostasis Products Market is expected to reach a valuation of US$ 2638 Million by 2032, at a CAGR of 5.3% | FMI
The global Hemostasis Products Market is expected to be worth US$ 1580 million in 2022. The market is expected to be worth US$ 2638 million between 2022 and 2032, at a CAGR of 5.3%. The rising prevalence of chronic blood disorders can be attributed to the market’s expansion. High-level technological advancements, strong economies, and a …
Clostridium Diagnostics Market in the United Kingdom is expected to be worth US$ 330 million by 2032 | FMI Study
The global Clostridium Diagnostics Market is anticipated to grow at a 12.2% CAGR from 2022 to 2032, from US$ 2.5 billion to US$ 7.8 billion. The market saw a 13.6% CAGR between 2015 and 2021. The market is expanding as a result of increased awareness-raising activities for clostridium-related illnesses and their rising prevalence. There has been an …
DNA Synthesis Market is likely to hold a valuation of US$ 592.1 million by 2032 | FMI Analyst
The DNA Synthesis Market is expected to grow at a 7.7% CAGR during the projected period. In 2022, the market is expected to be valued at US$ 261.9 million, rising to US$ 592.1 million in 2032. the DNA synthesis market is fueled by the growing application of the same in different end-use industries like agricultural science, …
Veterinary Glucometers Market is expected to reach a valuation of US$ 579.4 Million by 2032 | FMI Study
Veterinary Glucometers Market is expected to expand at a 5.1% CAGR through 2032. The worldwide veterinary glucometers market is presently valued at US$ 336.2 Million in 2022 and is expected to exceed US$ 579.4 Million by 2032. Emerging Trends in the veterinary glucometers market suggest the growing cases of animal diabetes along with glucometers efficiency, …
North American region is anticipated to lead the Osteonecrosis Treatment Market during the forecast through 2032 | FMI
The Osteonecrosis Treatment Market is anticipated to grow at a CAGR of 4.80% over the forecast period, rising from US$ 275.3 million in 2022 to US$ 461.7 million in 2032. Osteonecrosis is a disease associated with reduced blood flow to the bones. With the little blood flow, bone starts to die. Osteonecrosis is also known …
Global Hyperammonemia Treatment Market is likely to register CAGR of 4.77% through 2033
According to a recent Future Market Insights analysis, the global hyperammonemia treatment market is anticipated to reach a valuation of US$ 1,318.05 Million in 2023 and US$ 2,100 Million by 2033, with a CAGR of 4.77%. The increased frequency of urea cycle diseases, as well as extensive research and development, are driving the growth of …
Europe Alcohol Use Disorder Treatment Market is expected to grow at a CAGR of 6.3% during the forecast period 2023 to 2033
A recently published study by FMI expects the global alcohol use disorder treatment market demand to augment at a 6.4% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1300 million is expected for the market. The growing number of drug awareness campaigns, preventative programs, and technological …
Bartonellosis Therapeutics Market is anticipated to reach US$ 3.72 Billion by 2033
According to a recent report published by Future Market Insights, the global bartonellosis therapeutics market is slated to grow at a CAGR of 12% from 2023 to 2033, reaching a market value of US$ 3.72 Billion by the end of the said period of assessment. A robust product pipeline, in addition to upcoming launches, propelling …